IRIS Institutional Research Information System - OPENBS Open Archive UniBS

GENNARELLI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.060
AS - Asia 10.434
EU - Europa 8.561
SA - Sud America 2.186
Continente sconosciuto - Info sul continente non disponibili 560
AF - Africa 239
OC - Oceania 31
AN - Antartide 1
Totale 44.072
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.632
CN - Cina 3.737
SG - Singapore 3.292
UA - Ucraina 1.999
BR - Brasile 1.799
IT - Italia 1.316
HK - Hong Kong 1.160
PL - Polonia 1.129
DE - Germania 1.095
FR - Francia 776
VN - Vietnam 767
FI - Finlandia 605
GB - Regno Unito 556
TR - Turchia 372
BD - Bangladesh 361
RU - Federazione Russa 334
IE - Irlanda 328
IN - India 234
CA - Canada 209
AR - Argentina 163
MX - Messico 116
ZA - Sudafrica 80
IQ - Iraq 70
ID - Indonesia 68
SE - Svezia 66
NL - Olanda 59
ES - Italia 57
EC - Ecuador 56
PK - Pakistan 51
JP - Giappone 45
BE - Belgio 43
CZ - Repubblica Ceca 42
AT - Austria 41
CO - Colombia 38
VE - Venezuela 38
SA - Arabia Saudita 37
MA - Marocco 34
CL - Cile 33
PY - Paraguay 28
AU - Australia 27
NG - Nigeria 26
KE - Kenya 24
UZ - Uzbekistan 24
JM - Giamaica 23
CH - Svizzera 22
IR - Iran 22
EU - Europa 21
JO - Giordania 21
LT - Lituania 20
EG - Egitto 18
PE - Perù 15
PH - Filippine 15
TN - Tunisia 15
AE - Emirati Arabi Uniti 14
IL - Israele 14
NP - Nepal 14
TT - Trinidad e Tobago 14
KR - Corea 13
CR - Costa Rica 11
HN - Honduras 11
AZ - Azerbaigian 10
BG - Bulgaria 10
BH - Bahrain 10
KZ - Kazakistan 10
UY - Uruguay 10
DZ - Algeria 9
KG - Kirghizistan 9
MY - Malesia 9
OM - Oman 9
PA - Panama 9
DO - Repubblica Dominicana 8
ET - Etiopia 8
HU - Ungheria 8
MU - Mauritius 8
AL - Albania 7
RO - Romania 7
TW - Taiwan 7
GT - Guatemala 6
LV - Lettonia 6
SV - El Salvador 6
SY - Repubblica araba siriana 6
BO - Bolivia 5
BY - Bielorussia 5
GE - Georgia 5
KW - Kuwait 5
PT - Portogallo 5
AO - Angola 4
BB - Barbados 4
DK - Danimarca 4
LU - Lussemburgo 4
NI - Nicaragua 4
NO - Norvegia 4
PS - Palestinian Territory 4
TH - Thailandia 4
CI - Costa d'Avorio 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
LK - Sri Lanka 3
LY - Libia 3
PR - Porto Rico 3
Totale 43.497
Salva come PNG Salva come JPEG
Città #
Fairfield 2.491
Woodbridge 1.991
Singapore 1.816
Ashburn 1.803
Jacksonville 1.432
Houston 1.291
Hong Kong 1.152
Warsaw 1.122
Ann Arbor 1.076
Cambridge 1.008
Seattle 947
Wilmington 832
San Jose 726
Chandler 654
Beijing 640
Princeton 602
The Dalles 598
Nanjing 517
New York 444
Council Bluffs 375
Los Angeles 347
Brescia 324
Dublin 323
Lauterbourg 304
Istanbul 293
Columbus 288
Helsinki 288
Ho Chi Minh City 267
Dearborn 230
Nanchang 212
Des Moines 206
Munich 171
Buffalo 169
São Paulo 166
Milan 165
Shenyang 157
Changsha 143
Hebei 139
Hanoi 138
San Diego 136
Moscow 126
Shanghai 124
Chicago 115
Dallas 115
Redondo Beach 115
San Francisco 114
Santa Clara 108
Lancaster 107
Jinan 104
Tianjin 94
Jiaxing 86
Orem 79
London 78
Dong Ket 68
Verona 67
Hangzhou 65
Kunming 64
Turku 61
Frankfurt am Main 60
Boardman 57
Norwalk 57
Toronto 54
Guangzhou 53
Rio de Janeiro 53
Rome 53
Montreal 52
Nuremberg 52
Zhengzhou 52
Mexico City 51
Brooklyn 50
Lanzhou 50
Ningbo 48
Belo Horizonte 47
Johannesburg 44
Brussels 42
Denver 42
Phoenix 41
Atlanta 40
Haikou 39
Tokyo 39
Haiphong 36
Romola 34
San Mateo 34
Bolzano 33
Naples 32
Brasília 30
Chennai 30
Jakarta 30
Stockholm 30
Washington 28
Leawood 27
Brno 26
Abuja 25
Dhaka 25
Manchester 25
Porto Alegre 25
Augusta 24
Campinas 24
Kocaeli 24
Mumbai 24
Totale 29.315
Salva come PNG Salva come JPEG
Nome #
Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling 332
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 324
New Copy Number Variations in Schizophrenia 322
Compound heterozygosity for a large CNV deletion and a rare missense mutation in the FSTL5 gene of a patient affected by schizophrenia. 308
The effect of childhood trauma on blood transcriptome expression in major depressive disorder 265
Biomarkers and attention-deficit/hyperactivity disorder: a systematic review and meta-analyses. 261
Mutation within TARDBP leads to Frontotemporal Dementia without motor neuron disease. 257
Genome-wide analysis of consistently RNA edited sites in human blood reveals interactions with mRNA processing genes and suggests correlations with cell types and biological variables 254
Acute Footshock Stress Induces Time-Dependent Modifications of AMPA/NMDA Protein Expression and AMPA Phosphorylation 238
Copy number variants in attention-deficit hyperactive disorder: identification of the 15q13 deletion and its functional role. 236
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 235
Compound heterozygosity for a hemizygous rare missense variant (rs141999351) and a large CNV deletion affecting the FSTL5 gene in a patient with schizophrenia 231
Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood 229
Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder Patients 219
New biological pathways for major depression: gene expression decomposition in G x E components 215
Genomic restricted maximum likelihood (GREML) analysis to estimate the heritability of response/resistance in major depressive disorder (MDD) 211
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 210
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 208
Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans. 204
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 201
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 196
The role of the potassium channel gene KCNK2 in major depressive disorder 195
Gene per la neuregulina 1 e schizofrenia: ulteriori evidenze di associazione 193
Long-Term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms. 191
Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder 188
Association study and mutational screening of SYNGR1 as a candidate susceptibility gene for schizophrenia 187
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 187
Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment. 185
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 185
Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. 183
5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression 182
TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. 182
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD 181
The role of GRIK4 gene in treatment-resistant depression 180
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 179
Analysis of Copy Number Variations in Schizophrenia Italian Patients 177
Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline 'Predictors' and Longitudinal 'Targets' 177
A genome-wide investigation of SNPs and CNVs in schizophrenia. 176
3' UTR (AGG)n repeat of glial cell line-derived neurotrophic factor (GDNF) gene polymorphism in schizophrenia. 175
The Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders 175
A putative regulatory subunit (NR3A) of the NMDA receptor complex as candidate gene for susceptibility to schizophrenia: a case-control study. 175
Glucose metabolism alterations in patients with bipolar disorder 174
Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders. 174
BDNF Val66Met polymorphism and protein levels in amniotic fluid. 173
Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. 173
Next Generation Sequencing Analysis in Early Onset Dementia Patients 172
A genome-wide pharmacogenomic study of patients with schizophrenia suggests that GRM7 mediates the effects of risperidone on positive symptoms 169
Functional study of a novel homozygous mutation in the GAD1 gene, detected in a patient with schizophrenia. 168
Unraveling epigenomic signatures and effectiveness of electroconvulsive therapy in treatment-resistant depression patients: a prospective longitudinal study 167
The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association study. 167
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients. 166
Leucine-Rich Repeat Kinase-2 Controls the Differentiation and Maturation of Oligodendrocytes in Mice and Zebrafish 165
Derivation of midbrain dopaminergic neurons from human inducible pluripotent stem cells to model neurological disorders. 165
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 165
BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects. 161
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders. 161
Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis. 161
Acute Stress Responsiveness of the Neurotrophin BDNF in the Rat Hippocampus is Modulated by Chronic Treatment with the Antidepressant Duloxetine. 160
MTHFR: Genetic variants, expression analysis and COMT interaction in major depressive disorder 160
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 160
Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. 157
Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus 157
BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients 156
Dementia, delusions and seizures: storage disease or genetic AD? 155
A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial. 155
The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia 155
An association of GRIK3 Ser310Ala functional polymorphism with personality traits. 154
Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels 154
PCLO gene: Its role in vulnerability to major depressive disorder. 154
Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis. 153
Immune and metabolic alterations in first episode psychosis (FEP) patients 152
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 151
Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series 151
Serum sortilin-derived propeptides concentrations are decreased in major depressive disorder patients 151
miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease 150
The influence of psychiatric screening in healthy populations selection: a new study and meta-analysis of functional 5-HTTLPR and rs25531 polymorphisms and anxiety-related personality traits. 149
Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes. 149
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD). 149
Heterozygous TREM2 mutations in frontotemporal dementia 149
VEGF Haplotypes are Associated with Increased Risk to Progressive Supranuclear Palsy and Corticobasal Syndrome. 148
Blood microRNA changes in depressed patients during antidepressant treatment. 148
Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first-episode psychosis 148
Alterations of Brain-Derived Neurotrophic Factor Serum Levels in Patients with Alcohol Dependence. 147
ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder. 147
Erbb3 leukocytes mRNA levels as biomarker of Major Depression. 146
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 146
Exome sequencing of schizophrenia patients with high level of homozygosity identifies a homozygous novel mutation that reduces the glutamate acid decarboxylase 67 (GAD67) activity 146
The Expression of VGF is Reduced in Leukocytes of Depressed Patients and it is Restored by Effective Antidepressant Treatment 145
INFLAMMATORY AND NEUROTROPHIC FACTORS UNBALANCE IN LEUKOCYTES OF FIRST EPISODE PSYCHOSIS PATIENTS 145
A single polymerase chain reaction-based protocol for detecting normal and expanded alleles in myotonic dystrophy. 143
Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients 143
α-Synuclein and Glia in Parkinson’s Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System? 142
Possible Influence of a Non-Synonymous Polymorphism Located in the NGF Precursor on Susceptibility to Late-Onset Alzheimer's Disease and Mild Cognitive Impairment. 142
Association study between schizophrenia and the AMPA genes GRIA1, GRIA2 AND GRIA4 141
Progranulin genetic variations in frontotemporal lobar degeneration: evidence for low mutation frequency in an Italian clinical series. 141
Genetic variations and association. 141
Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients 140
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 140
Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: a case-control study. 139
Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: Comparison with methylphenidate. 139
Totale 17.888
Salva come PNG Salva come JPEG
Categoria #
all - tutte 215.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 215.038
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.238 0 541 56 56 14 98 206 142 172 238 206 509
2022/20232.084 349 12 31 146 190 620 6 208 315 32 94 81
2023/20242.135 127 52 188 131 95 349 60 72 588 37 37 399
2024/20255.439 47 55 82 615 592 516 392 189 513 585 1.034 819
2025/202611.700 1.042 1.622 852 1.769 1.142 762 1.602 471 725 930 497 286
2026/20271.203 605 598 0 0 0 0 0 0 0 0 0 0
Totale 44.072